Hydroxyurea for sickle cell disease

References

Citations

1. Steinberg MH, et al. (2003). Effects of hydroxyurea on mortality and morbidity in adult sickle cell anemia. JAMA, 289(13): 1645–1651.

2. Steinberg MH (1999). Management of sickle cell disease. New England Journal of Medicine, 340(13): 1021–1030.

3. Wang WC, et al. (2001). A two-year pilot trial of hydroxyurea in very young children with sickle cell anemia. Journal of Pediatrics, 139(6): 790–796.

4. Wang WC, et al. (2002). Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUG-KIDS Study. Journal of Pediatrics, 140(2): 225–229.

Author:	Debby Golonka, MPH	Last Updated: January 19, 2007
Medical Review:	Anne C. Poinier, MD - Internal Medicine Martin Steinberg, MD - Hematology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.